Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 15985-39-4
2. (2s)-2-amino-4-(s-methylsulfonimidoyl)butanoic Acid
3. L-methionine-s,r-sulfoximine
4. L-methionine [r,s]-sulfoximine
5. Butanoic Acid, 2-amino-4-(s-methylsulfonimidoyl)-, (2s)-
6. L-s-(3-amino-3-carboxypropyl)-s-methylsulfoximine
7. L-methionine-(s,r)-sulfoximine
8. De3d2pz3tt
9. Methionine Sulfoximine (l)
10. M9p6yz6jx9
11. Methionine Sulfoximine, (s)-
12. Chebi:28490
13. (2s)-2-amino-4-(s-methylsufonimidoyl)butanoic Acid
14. L-methionine-dl-sulfoximine
15. 2s-amino-4-(s-methylsulfonimidoyl)-butanoic Acid
16. L-methionine [s]-sulfoximine
17. 21752-32-9
18. (2s)-2-amino-4-((s(s))-s-methylsulfonimidoyl)butanoic Acid
19. Butanoic Acid, 2-amino-4-((s(s))-s-methylsulfonimidoyl)-, (2s)-
20. (2s)-2-amino-4-(methylsulfonimidoyl)butanoic Acid
21. 7x87yr5kvs
22. Methionine Sulfoximine, (r)-
23. Unii-m9p6yz6jx9
24. (2s)-2-amino-4-[imino(methyl)oxo-
25. E?-sulfanyl]butanoic Acid
26. Prestwick_805
27. L-methionine-sulfoximine
28. Prestwick0_000523
29. Prestwick1_000523
30. Prestwick2_000523
31. Prestwick3_000523
32. Unii-de3d2pz3tt
33. Lopac0_000797
34. Bspbio_000505
35. Schembl187872
36. Spbio_002426
37. Bpbio1_000557
38. Chembl143324
39. Methionine-dl-sulfoximine
40. Chembl1627202
41. Butanoic Acid, 2-amino-4-(s-methylsufonimidoyl)-, (2s)-
42. Dtxsid30936181
43. Hms1569j07
44. Hms2096j07
45. Hms3262o16
46. Bcp10104
47. Hy-b1692
48. Tox21_500797
49. L-methionine-(r)-sulfoximine
50. Mfcd00063094
51. Methionine-dl-sulfoximine, L-
52. Akos015892783
53. (2s,sr)-methionine Sulfoximine
54. Ccg-204881
55. Db14103
56. Lp00797
57. Sdccgsbi-0050774.p002
58. Ncgc00094132-01
59. Ncgc00094132-02
60. Ncgc00094132-03
61. Ncgc00094132-04
62. Ncgc00094132-07
63. Ncgc00261482-01
64. As-40141
65. Ds-018180
66. Ab00513853
67. Cs-0013677
68. Eu-0100797
69. C03510
70. M 5379
71. A810076
72. Sr-01000075995
73. J-009648
74. Sr-01000075995-1
75. (2s)-2-amino-4-(s-methylsufonimidoyl)-butanoic Acid
76. Q27103738
77. (2s)-2-amino-4-((s(r))-s-methylsulfonimidoyl)butanoic Acid
78. L-methionine Sulfoximine, Certified Reference Material, Tracecert(r)
79. Butanoic Acid, 2-amino-4-((s(r))-s-methylsulfonimidoyl)-, (2s)-
80. L-methionine Sulfoximine, Pharmagrade, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production.
81. Mso
| Molecular Weight | 180.23 g/mol |
|---|---|
| Molecular Formula | C5H12N2O3S |
| XLogP3 | -1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 180.05686342 g/mol |
| Monoisotopic Mass | 180.05686342 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 244 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A L-Methionine Sulfoximine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Methionine Sulfoximine, including repackagers and relabelers. The FDA regulates L-Methionine Sulfoximine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Methionine Sulfoximine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A L-Methionine Sulfoximine supplier is an individual or a company that provides L-Methionine Sulfoximine active pharmaceutical ingredient (API) or L-Methionine Sulfoximine finished formulations upon request. The L-Methionine Sulfoximine suppliers may include L-Methionine Sulfoximine API manufacturers, exporters, distributors and traders.
click here to find a list of L-Methionine Sulfoximine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Methionine Sulfoximine DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Methionine Sulfoximine active pharmaceutical ingredient (API) in detail. Different forms of L-Methionine Sulfoximine DMFs exist exist since differing nations have different regulations, such as L-Methionine Sulfoximine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Methionine Sulfoximine DMF submitted to regulatory agencies in the US is known as a USDMF. L-Methionine Sulfoximine USDMF includes data on L-Methionine Sulfoximine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Methionine Sulfoximine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Methionine Sulfoximine suppliers with USDMF on PharmaCompass.
L-Methionine Sulfoximine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Methionine Sulfoximine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Methionine Sulfoximine GMP manufacturer or L-Methionine Sulfoximine GMP API supplier for your needs.
A L-Methionine Sulfoximine CoA (Certificate of Analysis) is a formal document that attests to L-Methionine Sulfoximine's compliance with L-Methionine Sulfoximine specifications and serves as a tool for batch-level quality control.
L-Methionine Sulfoximine CoA mostly includes findings from lab analyses of a specific batch. For each L-Methionine Sulfoximine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Methionine Sulfoximine may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Methionine Sulfoximine EP), L-Methionine Sulfoximine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Methionine Sulfoximine USP).
LOOKING FOR A SUPPLIER?
